Could a common pill stop painful kidney stones?
NCT ID NCT07055282
Summary
This early study is testing if a medication called empagliflozin, usually used for diabetes and heart health, can change urine chemistry to help prevent calcium-based kidney stones from forming again. Researchers will give the drug to 32 adults with a history of these stones for four weeks, measuring changes in their urine. The goal is to see if this approach is promising enough to test in larger future studies for stone prevention.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY STONES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Chicago
RECRUITINGChicago, Illinois, 60637, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.